These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 16210414

  • 1. Daily, intermittent intravenous infusion of peptide YY(3-36) reduces daily food intake and adiposity in rats.
    Chelikani PK, Haver AC, Reeve JR, Keire DA, Reidelberger RD.
    Am J Physiol Regul Integr Comp Physiol; 2006 Feb; 290(2):R298-305. PubMed ID: 16210414
    [Abstract] [Full Text] [Related]

  • 2. Intermittent intraperitoneal infusion of peptide YY(3-36) reduces daily food intake and adiposity in obese rats.
    Chelikani PK, Haver AC, Reidelberger RD.
    Am J Physiol Regul Integr Comp Physiol; 2007 Jul; 293(1):R39-46. PubMed ID: 17428898
    [Abstract] [Full Text] [Related]

  • 3. Effects of different intermittent peptide YY (3-36) dosing strategies on food intake, body weight, and adiposity in diet-induced obese rats.
    Reidelberger RD, Haver AC, Chelikani PK, Buescher JL.
    Am J Physiol Regul Integr Comp Physiol; 2008 Aug; 295(2):R449-58. PubMed ID: 18550871
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Gut hormone PYY(3-36) physiologically inhibits food intake.
    Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, Cone RD, Bloom SR.
    Nature; 2002 Aug 08; 418(6898):650-4. PubMed ID: 12167864
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Role of capsaicin-sensitive peripheral sensory neurons in anorexic responses to intravenous infusions of cholecystokinin, peptide YY-(3-36), and glucagon-like peptide-1 in rats.
    Reidelberger R, Haver A, Anders K, Apenteng B.
    Am J Physiol Endocrinol Metab; 2014 Oct 15; 307(8):E619-29. PubMed ID: 25117406
    [Abstract] [Full Text] [Related]

  • 13. Leptin extends the anorectic effects of chronic PYY(3-36) administration in ad libitum-fed rats.
    Unniappan S, Kieffer TJ.
    Am J Physiol Regul Integr Comp Physiol; 2008 Jul 15; 295(1):R51-8. PubMed ID: 18417649
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of intermittent intraperitoneal infusion of salmon calcitonin on food intake and adiposity in obese rats.
    Chelikani PK, Haver AC, Reidelberger RD.
    Am J Physiol Regul Integr Comp Physiol; 2007 Nov 15; 293(5):R1798-808. PubMed ID: 17761508
    [Abstract] [Full Text] [Related]

  • 19. Combination therapy with amylin and peptide YY[3-36] in obese rodents: anorexigenic synergy and weight loss additivity.
    Roth JD, Coffey T, Jodka CM, Maier H, Athanacio JR, Mack CM, Weyer C, Parkes DG.
    Endocrinology; 2007 Dec 15; 148(12):6054-61. PubMed ID: 17761760
    [Abstract] [Full Text] [Related]

  • 20. Effect of subcutaneous injections of PYY1-36 and PYY3-36 on appetite, ad libitum energy intake, and plasma free fatty acid concentration in obese males.
    Sloth B, Davidsen L, Holst JJ, Flint A, Astrup A.
    Am J Physiol Endocrinol Metab; 2007 Aug 15; 293(2):E604-9. PubMed ID: 17566112
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.